Article ID Journal Published Year Pages File Type
2028124 Steroids 2012 4 Pages PDF
Abstract

Women with polycystic ovary syndrome have gynecologic, reproductive and metabolic co-morbidities that span their entire lifespan. More recently a higher risk of mood and anxiety disorders has been reported in women with PCOS. Women with PCOS have higher depression scores and a higher risk of depression independent of BMI. Although clinical features of hyperandrogenism affect health related quality of life, the association between hirsutism, acne, body image and depression is currently unclear. Similarly there is limited data on the association between variables such as biochemical hyperandrogenism or infertility and depression. Women with PCOS are also at risk for symptoms of generalized anxiety disorder. There is insufficient data examining the risk of other anxiety disorders such as social phobia, obsessive compulsive disorders and panic disorder. In a number of patients some of these disorders coexist increasing the health burden. These data underscore the need to screen all women with PCOS for mood and anxiety disorders and adequately treat women who are diagnosed with these conditions.

► Women with PCOS have increased risk of depressive symptoms. ► Risk of depression is independent of BMI. ► Relationship to infertility, hirsutism, serum androgens is unclear. ► Women with PCOS have increased risk of anxiety symptoms.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Biochemistry
Authors
,